GUT ISCHEMIA INDUCES BONE-MARROW FAILURE AND INCREASES RISK OF INFECTION

被引:28
|
作者
FONTES, B [1 ]
MOORE, FA [1 ]
MOORE, EE [1 ]
KOIKE, K [1 ]
KIM, F [1 ]
TREW, CE [1 ]
PETERSON, VM [1 ]
机构
[1] UNIV COLORADO, HLTH SCI CTR, DEPT SURG, DENVER, CO 80220 USA
关键词
D O I
10.1006/jsre.1994.1176
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hemorrhagic shock leads to bone marrow (BM) failure and renders the host susceptible to infection. We hypothesized that splanchnic hypoperfusion may play a mechanistic role in this process. BM was harvested from normal rats and, on Postprocedure Days 1 and 3, from rats that had undergone laparotomy (LAP) or gut ischemia/reperfusion (I/R; 45 min superior mesentery artery occlusion). Granulocyte-macrophage colony-forming unit (CFU-GM) proliferation, a measure of BM myeloid progenitors, was quantitated using a standard soft agar culture technique. On Postprocedure Days 1 and 3, BM proliferation of CFU-GM was depressed in gut I/R rats, compared to control and LAP animals (P < 0.05). Next, six rats were subjected to I/R, LAP, ANEST (anesthesia control), or no treatment (NL, normal control); 1 day later, 3.5 x 10(7) Staphylococcus aureus, suspended in 0.25 ml of saline, were injected subcutaneously in four sites on the back of each animal. Five days later, the NL rats had developed 23 abscesses, ANEST 23, and LAP 22, while the gut I/R rats had 24. The abscesses were excised, weighed, and measured. The weight and size of abscesses were greater in the gut I/R animals (P < 0.05). In summary, gut I/R depressed BM proliferation and rendered animals susceptible to infection in a manner similar to that observed following hemorrhagic shock. These data suggest that splanchnic hypoperfusion, a common sequela of hemorrhagic shock, may play a mechanistic role in BM failure and infection after hemorrhage. (C) 1994 Academic Press, Inc.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 50 条
  • [41] ANESTHETIC MANAGEMENT OF PATIENTS WITH BONE-MARROW FAILURE
    BRUCE, DL
    KOEPKE, JA
    ANESTHESIA AND ANALGESIA CURRENT RESEARCHES, 1972, 51 (04): : 597 - &
  • [42] Renal failure after bone-marrow transplantation
    Cohen, EP
    LANCET, 2001, 357 (9249): : 6 - 7
  • [43] TRANSPLANTATION OF BONE-MARROW IN REFRACTORY MARROW FAILURE AND NEOPLASTIC DISEASES
    STORB, R
    THOMAS, ED
    BUCKNER, CD
    CLIFT, RA
    FEFER, A
    GLUCKSBERG, H
    NEIMAN, PE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1974, 62 (02) : 212 - 217
  • [44] BONE-MARROW FAILURE - PATHOPHYSIOLOGY AND MANAGEMENT - FOREWORD
    BONE, RC
    DM DISEASE-A-MONTH, 1995, 41 (04): : 205 - 289
  • [45] BONE-MARROW FAILURE WITH PLASMOCYTOSIS IN A DIABETIC CHILD
    MUTZ, ID
    MESSNER, H
    URBAN, C
    KLINISCHE PADIATRIE, 1980, 192 (06): : 573 - 576
  • [46] OXYMETHOLONE TREATMENT FOR ANEMIA OF BONE-MARROW FAILURE
    ALEXANIAN, R
    ALFREY, C
    NADELL, J
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (03): : 353 - +
  • [47] CHERNOBYL BONE-MARROW TRANSPLANTS WERE A FAILURE
    不详
    NEW SCIENTIST, 1986, 111 (1524) : 18 - 19
  • [48] HIV-INFECTION AND BONE-MARROW TRANSPLANTATION
    BANDINI, G
    RE, MC
    ROSTI, G
    BELARDINELLI, AR
    LANCET, 1991, 337 (8750): : 1163 - 1164
  • [49] BONE-MARROW NECROSIS ASSOCIATED WITH A MUCOR INFECTION
    CARAVEO, J
    TROWBRIDGE, AA
    AMARAL, BW
    GREEN, JB
    CAIN, PT
    HURLEY, DL
    AMERICAN JOURNAL OF MEDICINE, 1977, 62 (03): : 404 - 408
  • [50] BONE-MARROW STUDIES IN PATIENTS WITH HIV INFECTION
    SUN, NCJ
    SHAPSHAK, P
    LACHANT, N
    HSU, MY
    BEALL, G
    IMAGAWA, D
    MODERN PATHOLOGY, 1988, 1 (01) : A89 - A89